Lynx1 Capital Management as of Sept. 30, 2024
Portfolio Holdings for Lynx1 Capital Management
Lynx1 Capital Management holds 18 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 31.8 | $90M | 1.8M | 49.96 | |
| Stoke Therapeutics (STOK) | 22.6 | $64M | 5.2M | 12.29 | |
| C4 Therapeutics Com Stk (CCCC) | 13.9 | $39M | 6.9M | 5.70 | |
| Gh Research Ordinary Shares (GHRS) | 9.9 | $28M | 4.2M | 6.69 | |
| Tscan Therapeutics (TCRX) | 9.2 | $26M | 5.2M | 4.98 | |
| Allogene Therapeutics (ALLO) | 6.2 | $17M | 6.2M | 2.80 | |
| Cullinan Oncology (CGEM) | 2.4 | $6.9M | 411k | 16.74 | |
| Passage Bio | 2.1 | $5.9M | 8.4M | 0.70 | |
| Ibio Con New (IBIO) | 0.7 | $1.9M | 862k | 2.22 | |
| Caribou Biosciences (CRBU) | 0.5 | $1.3M | 680k | 1.96 | |
| Kodiak Sciences (KOD) | 0.3 | $708k | 271k | 2.61 | |
| Pieris Pharmaceuticals Com New | 0.2 | $621k | 37k | 16.58 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.1 | $278k | 17k | 15.99 | |
| Bionomics Ads | 0.1 | $242k | 550k | 0.44 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.1 | $206k | 8.2k | 24.99 | |
| Tenax Therapeutics Com New (TENX) | 0.0 | $51k | 15k | 3.46 | |
| Century Therapeutics (IPSC) | 0.0 | $33k | 19k | 1.71 | |
| Vyne Therapeutics (VYNE) | 0.0 | $30k | 16k | 1.88 |
